TulpuleALenschMWMillerJD. Knockdown of Fanconi anemia genes in human embryonic stem cells reveals early developmental defects in the hematopoietic lineage. Blood. 2010;115:3453-3462.
2.
KeeYD’AndreaAD.Molecular pathogenesis and clinical management of Fanconi anemia. J Clin Invest. 2012;122:3799.
3.
WangATSmogorzewskaA.SnapShot: Fanconi anemia and associated proteins. Cell. 2015;160:354-354.e1.
4.
KhinchaPPSavageSA.Neonatal manifestations of inherited bone marrow failure syndromes. Semin Fetal Neonatal Med. 2016;21:57-65.
5.
BabushokDVBesslerM.Genetic predisposition syndromes: when should they be considered in the work-up of MDS?Best Pract Res Clin Haematol. 2015;28:55-68.
6.
AuerbachAD.Fanconi anemia and its diagnosis. Mutat Res. 2009;668:4-10.
7.
SchneiderMChandlerKTischkowitzMMeyerS.Fanconi anaemia: genetics, molecular biology, and cancer—implications for clinical management in children and adults. Clin Genet. 2015;88:13-24.
UmañaLAMagoulasPBiWBacinoCA.A male newborn with VACTERL association and Fanconi anemia with a FANCB deletion detected by array comparative genomic hybridization (aCGH). Am J Med Genet A. 2011;155:3071-3074.
10.
KanemotoNFukushimaTImotoNKoikeKKanemotoKMatsuuraS.Sporadic neonatal Fanconi’s anemia with VACTERL association. Pediatr Int. 2010;52:141-142.
11.
LandmannEBluetters-SawatzkiRSchindlerDGortnerL.Fanconi anemia in a neonate with pancytopenia. J Pediatr. 2004;145:125-127.
12.
TolarJBeckerPSClappDW. Gene therapy for Fanconi anemia: one step closer to the clinic. Hum Gene Ther. 2012;23:141-144.
